Tyler D, Mandybur G, Dhillon G, Fratkin J
Department of Neurosurgery, University of Mississippi, Jackson, USA.
Neurosurgery. 2001 Apr;48(4):937-9; discussion 939-40. doi: 10.1097/00006123-200104000-00052.
Parathyroid carcinoma is a rare entity, and fewer than 200 cases have been described. It is a slowly progressive disease characterized by frequent recurrences and local metastases. Most patients with parathyroid carcinoma die from metabolic complications of hyperparathyroidism. Five-year survival rates range from 25 to 50%. Functional parathyroid carcinoma is a rare cause of hyperparathyroidism that affects only 0.32 to 5% of all patients who undergo surgery for hypercalcemia. A review of the literature revealed only one other reported case of metastatic intracranial parathyroid carcinoma, in a patient who experienced local recurrence and metastatic disease when she was diagnosed with an intracranial lesion.
We report the case of a 44-year-old African-American man with recent-onset, right lower-extremity weakness and hypercalcemia 4 years after he underwent a parathyroidectomy for parathyroid carcinoma. At presentation, his parathyroid level was 467 pg/ml, and his serum calcium level was 15.2 mg/dl. Imaging studies revealed an isolated enhancing left mesial frontoparietal mass. A systemic Cardiolite study demonstrated a single focus of radiotracer uptake in this region. No abnormal uptake was demonstrated in the neck or elsewhere.
The patient underwent a frameless stereotactic interventional magnetic resonance imaging-guided resection via a parasagittal interhemispheric approach. Pathological findings were consistent with parathyroid carcinoma. After resection, his right lower-extremity weakness and secondary hyperparathyroidism resolved.
The typical natural history of parathyroid carcinoma concludes with death from complications of hyperparathyroidism. This case report supports aggressive surgical management to eliminate all parathyroid hormone-secreting malignant tissue and prevent metabolic complications. In this patient, intraoperative magnetic resonance imaging was helpful to ensure complete resection.
甲状旁腺癌是一种罕见疾病,所报道的病例少于200例。它是一种进展缓慢的疾病,其特征是频繁复发和局部转移。大多数甲状旁腺癌患者死于甲状旁腺功能亢进的代谢并发症。五年生存率为25%至50%。功能性甲状旁腺癌是甲状旁腺功能亢进的罕见病因,仅占所有因高钙血症接受手术患者的0.32%至5%。文献回顾显示,仅有另一例转移性颅内甲状旁腺癌的报道,该患者在被诊断为颅内病变时已出现局部复发和转移性疾病。
我们报告一例44岁非裔美国男性病例,他在因甲状旁腺癌接受甲状旁腺切除术后4年出现右下肢无力和高钙血症。就诊时,他的甲状旁腺素水平为467 pg/ml,血清钙水平为15.2 mg/dl。影像学检查显示左侧额顶叶内侧有一个孤立的强化肿块。全身心肌显像研究显示该区域有单个放射性示踪剂摄取点。颈部或其他部位未显示异常摄取。
患者通过经矢状旁半球间入路接受了无框架立体定向介入磁共振成像引导下的切除术。病理结果与甲状旁腺癌一致。切除术后,他的右下肢无力和继发性甲状旁腺功能亢进症状得到缓解。
甲状旁腺癌的典型自然病程以甲状旁腺功能亢进并发症导致的死亡告终。本病例报告支持积极的手术治疗,以清除所有分泌甲状旁腺激素的恶性组织并预防代谢并发症。在该患者中,术中磁共振成像有助于确保完全切除。